These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31837249)
1. Impact of mast cells in fibromyalgia and low-grade chronic inflammation: Can IL-37 play a role? Conti P; Gallenga CE; Caraffa A; Ronconi G; Kritas SK Dermatol Ther; 2020 Jan; 33(1):e13191. PubMed ID: 31837249 [TBL] [Abstract][Full Text] [Related]
2. Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. Mastrangelo F; Frydas I; Ronconi G; Kritas SK; Tettamanti L; Caraffa Al; D Ovidio C; Younes A; Gallenga CE; Conti P J Biol Regul Homeost Agents; 2018; 32(2):195-198. PubMed ID: 29684996 [TBL] [Abstract][Full Text] [Related]
3. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
4. Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. Salemi S; Rethage J; Wollina U; Michel BA; Gay RE; Gay S; Sprott H J Rheumatol; 2003 Jan; 30(1):146-50. PubMed ID: 12508404 [TBL] [Abstract][Full Text] [Related]
5. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial. Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882 [TBL] [Abstract][Full Text] [Related]
6. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra. Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845 [TBL] [Abstract][Full Text] [Related]
7. New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators. Caraffa Al; Conti C; D Ovidio C; Gallenga CE; Tettamanti L; Mastrangelo F; Ronconi G; Kritas SK; Conti P J Biol Regul Homeost Agents; 2018; 32(3):449-454. PubMed ID: 29921369 [TBL] [Abstract][Full Text] [Related]
17. Impact of mold on mast cell-cytokine immune response. Kritas SK; Gallenga CE; D Ovidio C; Ronconi G; Caraffa Al; Toniato E; Lauritano D; Conti P J Biol Regul Homeost Agents; 2018; 32(4):763-768. PubMed ID: 30043558 [TBL] [Abstract][Full Text] [Related]
18. Mast cell and cancer with special emphasis on il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers. Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa Al; Conti P J Biol Regul Homeost Agents; 2016; 30(4):945-950. PubMed ID: 28078840 [TBL] [Abstract][Full Text] [Related]
19. Machine Learning to Understand the Immune-Inflammatory Pathways in Fibromyalgia. Andrés-Rodríguez L; Borràs X; Feliu-Soler A; Pérez-Aranda A; Rozadilla-Sacanell A; Arranz B; Montero-Marin J; García-Campayo J; Angarita-Osorio N; Maes M; Luciano JV Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470635 [TBL] [Abstract][Full Text] [Related]
20. Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines. Lauritano D; Mastrangelo F; D'Ovidio C; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Trimarchi M; Carinci F; Conti P Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]